Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Recruiting

Lung Transplantation with AntiviralsCombined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Sponsor:

University Health Network, Toronto

Code:

NCT07189377

Conditions

Hepatitis B Virus (HBV)

Lung Transplant Recipient

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Entecavir

HBIG

EVLP UV Light Treatment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-20. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2025-11-17.